Loading…
Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes
The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery. An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing...
Saved in:
Published in: | International journal of pharmaceutics 2012-10, Vol.436 (1-2), p.564-567 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553 |
---|---|
cites | cdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553 |
container_end_page | 567 |
container_issue | 1-2 |
container_start_page | 564 |
container_title | International journal of pharmaceutics |
container_volume | 436 |
creator | Fujisawa, Takuya Miyai, Hiroko Hironaka, Kohei Tsukamoto, Toshimasa Tahara, Kohei Tozuka, Yuichi Ito, Masaki Takeuchi, Hirofumi |
description | The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery.
An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution. |
doi_str_mv | 10.1016/j.ijpharm.2012.07.024 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1037886259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517312007272</els_id><sourcerecordid>1037886259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</originalsourceid><addsrcrecordid>eNqFkc1u1DAcxC0EotvCIwA-cknwR_xRLqiqaEFaiQP0bDnO31uvkjjYSaV9BZ4aR1ngyMk-_GY8nkHoDSU1JVR-ONbhOD3aNNSMUFYTVRPWPEM7qhWveKPkc7QjXOlKUMUv0GXOR0KIZJS_RBeMaaaJYjv0ax-mmONge9wF10cPo3UYToC7FCfsYxqW3s4hjhnPNh1gDuMBz4-A03q1H_HdPwTn2bahD_MJh2FK8QkGGGe85FWTl-StAzzELvjgNkH0uN8CQH6FXnjbZ3h9Pq_Qw93nH7dfqv23-6-3N_vKNULMlfTXHW8aVv7lVEukpx0nnKpWeSKVaNtWcUcaQbT2LSVMWk2Ec1Ix3-niwK_Q-823JPy5QJ7NELKDvrcjxCUbutamJRPXBRUb6lLMOYE3UwqDTacCmXUGczTnGcw6gyHKlBmK7u35iaUdoPur-tN7Ad5tgLfR2EMK2Tx8Lw6CFBdBpS7Ep42AUsVTgGSyCzA66EICN5suhv-E-A2di6gQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1037886259</pqid></control><display><type>article</type><title>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</title><source>Elsevier</source><creator>Fujisawa, Takuya ; Miyai, Hiroko ; Hironaka, Kohei ; Tsukamoto, Toshimasa ; Tahara, Kohei ; Tozuka, Yuichi ; Ito, Masaki ; Takeuchi, Hirofumi</creator><creatorcontrib>Fujisawa, Takuya ; Miyai, Hiroko ; Hironaka, Kohei ; Tsukamoto, Toshimasa ; Tahara, Kohei ; Tozuka, Yuichi ; Ito, Masaki ; Takeuchi, Hirofumi</creatorcontrib><description>The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery.
An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2012.07.024</identifier><identifier>PMID: 22828072</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>acetates ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; calcium ; Calcium acetate gradient method ; Chemistry, Pharmaceutical ; Diclofenac ; Diclofenac - administration & dosage ; Diclofenac - chemistry ; Diclofenac - pharmacokinetics ; Drug Stability ; encapsulation ; Eye drop ; Liposome ; Liposomes ; Ophthalmic Solutions ; Particle Size ; polyvinyl alcohol ; Polyvinyl Alcohol - administration & dosage ; Polyvinyl Alcohol - chemistry ; Polyvinyl Alcohol - pharmacokinetics ; PVA ; Rabbits ; Retina ; Retina - metabolism ; Surface Properties</subject><ispartof>International journal of pharmaceutics, 2012-10, Vol.436 (1-2), p.564-567</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</citedby><cites>FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22828072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujisawa, Takuya</creatorcontrib><creatorcontrib>Miyai, Hiroko</creatorcontrib><creatorcontrib>Hironaka, Kohei</creatorcontrib><creatorcontrib>Tsukamoto, Toshimasa</creatorcontrib><creatorcontrib>Tahara, Kohei</creatorcontrib><creatorcontrib>Tozuka, Yuichi</creatorcontrib><creatorcontrib>Ito, Masaki</creatorcontrib><creatorcontrib>Takeuchi, Hirofumi</creatorcontrib><title>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery.
An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.</description><subject>acetates</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>calcium</subject><subject>Calcium acetate gradient method</subject><subject>Chemistry, Pharmaceutical</subject><subject>Diclofenac</subject><subject>Diclofenac - administration & dosage</subject><subject>Diclofenac - chemistry</subject><subject>Diclofenac - pharmacokinetics</subject><subject>Drug Stability</subject><subject>encapsulation</subject><subject>Eye drop</subject><subject>Liposome</subject><subject>Liposomes</subject><subject>Ophthalmic Solutions</subject><subject>Particle Size</subject><subject>polyvinyl alcohol</subject><subject>Polyvinyl Alcohol - administration & dosage</subject><subject>Polyvinyl Alcohol - chemistry</subject><subject>Polyvinyl Alcohol - pharmacokinetics</subject><subject>PVA</subject><subject>Rabbits</subject><subject>Retina</subject><subject>Retina - metabolism</subject><subject>Surface Properties</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAcxC0EotvCIwA-cknwR_xRLqiqaEFaiQP0bDnO31uvkjjYSaV9BZ4aR1ngyMk-_GY8nkHoDSU1JVR-ONbhOD3aNNSMUFYTVRPWPEM7qhWveKPkc7QjXOlKUMUv0GXOR0KIZJS_RBeMaaaJYjv0ax-mmONge9wF10cPo3UYToC7FCfsYxqW3s4hjhnPNh1gDuMBz4-A03q1H_HdPwTn2bahD_MJh2FK8QkGGGe85FWTl-StAzzELvjgNkH0uN8CQH6FXnjbZ3h9Pq_Qw93nH7dfqv23-6-3N_vKNULMlfTXHW8aVv7lVEukpx0nnKpWeSKVaNtWcUcaQbT2LSVMWk2Ec1Ix3-niwK_Q-823JPy5QJ7NELKDvrcjxCUbutamJRPXBRUb6lLMOYE3UwqDTacCmXUGczTnGcw6gyHKlBmK7u35iaUdoPur-tN7Ad5tgLfR2EMK2Tx8Lw6CFBdBpS7Ep42AUsVTgGSyCzA66EICN5suhv-E-A2di6gQ</recordid><startdate>20121015</startdate><enddate>20121015</enddate><creator>Fujisawa, Takuya</creator><creator>Miyai, Hiroko</creator><creator>Hironaka, Kohei</creator><creator>Tsukamoto, Toshimasa</creator><creator>Tahara, Kohei</creator><creator>Tozuka, Yuichi</creator><creator>Ito, Masaki</creator><creator>Takeuchi, Hirofumi</creator><general>Elsevier B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121015</creationdate><title>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</title><author>Fujisawa, Takuya ; Miyai, Hiroko ; Hironaka, Kohei ; Tsukamoto, Toshimasa ; Tahara, Kohei ; Tozuka, Yuichi ; Ito, Masaki ; Takeuchi, Hirofumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>acetates</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>calcium</topic><topic>Calcium acetate gradient method</topic><topic>Chemistry, Pharmaceutical</topic><topic>Diclofenac</topic><topic>Diclofenac - administration & dosage</topic><topic>Diclofenac - chemistry</topic><topic>Diclofenac - pharmacokinetics</topic><topic>Drug Stability</topic><topic>encapsulation</topic><topic>Eye drop</topic><topic>Liposome</topic><topic>Liposomes</topic><topic>Ophthalmic Solutions</topic><topic>Particle Size</topic><topic>polyvinyl alcohol</topic><topic>Polyvinyl Alcohol - administration & dosage</topic><topic>Polyvinyl Alcohol - chemistry</topic><topic>Polyvinyl Alcohol - pharmacokinetics</topic><topic>PVA</topic><topic>Rabbits</topic><topic>Retina</topic><topic>Retina - metabolism</topic><topic>Surface Properties</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujisawa, Takuya</creatorcontrib><creatorcontrib>Miyai, Hiroko</creatorcontrib><creatorcontrib>Hironaka, Kohei</creatorcontrib><creatorcontrib>Tsukamoto, Toshimasa</creatorcontrib><creatorcontrib>Tahara, Kohei</creatorcontrib><creatorcontrib>Tozuka, Yuichi</creatorcontrib><creatorcontrib>Ito, Masaki</creatorcontrib><creatorcontrib>Takeuchi, Hirofumi</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujisawa, Takuya</au><au>Miyai, Hiroko</au><au>Hironaka, Kohei</au><au>Tsukamoto, Toshimasa</au><au>Tahara, Kohei</au><au>Tozuka, Yuichi</au><au>Ito, Masaki</au><au>Takeuchi, Hirofumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2012-10-15</date><risdate>2012</risdate><volume>436</volume><issue>1-2</issue><spage>564</spage><epage>567</epage><pages>564-567</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>The modifying liposome surface with polyvinyl alcohol or its derivative prevented the liposome aggregation and/or fusion during remote loading process, leading to effective retinal delivery.
An efficient liposomal formulation for targeting the retina was produced as an optimal means of distributing therapeutic agents to the retina. Diclofenac was used as a model compound for liposome encapsulation, and the release rate and distribution to the retina were investigated. The calcium acetate gradient method was found to be the optimal method for encapsulating diclofenac into liposomes. Entrapment efficiency using this method was greater than 97%, whereas conventional hydration method achieved 51.3%. The resultant formulation obtained with the gradient method caused aggregation and/or fusion of liposomes. To avoid inhibition of retinal delivery due to the aggregation of the carrier, surface modification was performed simultaneously with the gradient method. The increase in particle size of the liposomal formulation clearly was inhibited for a long time in the presence of polyvinyl alcohol or its derivative. This observation may be explained by surface modification of the liposomes by physisorption or anchoring effect of polymers on the surface of the lipid bilayer. Furthermore, the sustained release profile of the diclofenac formulation was retained after modification. An in vivo animal study revealed that concentration of the accumulated diclofenac in the retina–choroid was enhanced 1.8-fold by surface-modified liposome entrapment compared to that of the unaltered diclofenac solution.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22828072</pmid><doi>10.1016/j.ijpharm.2012.07.024</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2012-10, Vol.436 (1-2), p.564-567 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_1037886259 |
source | Elsevier |
subjects | acetates Animals Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - chemistry Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics calcium Calcium acetate gradient method Chemistry, Pharmaceutical Diclofenac Diclofenac - administration & dosage Diclofenac - chemistry Diclofenac - pharmacokinetics Drug Stability encapsulation Eye drop Liposome Liposomes Ophthalmic Solutions Particle Size polyvinyl alcohol Polyvinyl Alcohol - administration & dosage Polyvinyl Alcohol - chemistry Polyvinyl Alcohol - pharmacokinetics PVA Rabbits Retina Retina - metabolism Surface Properties |
title | Liposomal diclofenac eye drop formulations targeting the retina: Formulation stability improvement using surface modification of liposomes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A47%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liposomal%20diclofenac%20eye%20drop%20formulations%20targeting%20the%20retina:%20Formulation%20stability%20improvement%20using%20surface%20modification%20of%20liposomes&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Fujisawa,%20Takuya&rft.date=2012-10-15&rft.volume=436&rft.issue=1-2&rft.spage=564&rft.epage=567&rft.pages=564-567&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2012.07.024&rft_dat=%3Cproquest_cross%3E1037886259%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-6f9d3442517c7b06f1d30317b7f0675bbb73c045088fb1026a805cc672fd84553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1037886259&rft_id=info:pmid/22828072&rfr_iscdi=true |